1
|
Liu Y, Daley S, Evdokimova VN, Zdobinski
DD, Potter DM and Butterfield LH: Hierarchy of alpha fetoprotein
(AFP)-specific T cell responses in subjects with AFP-positive
hepatocellular cancer. J Immunol. 177:712–721. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Butterfield LH, Koh A, Meng W, et al:
Generation of human T cell responses to an HLA-A2.1-restricted
peptide epitope from alpha-fetoprotein. Cancer Res. 59:3134–3142.
1999.PubMed/NCBI
|
3
|
Butterfield LH, Meng WS, Koh A, et al: T
cell responses To HLA-A*0201-restricted peptides derived from human
alpha fetoprotein. J Immunol. 166:5300–5308. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Steinman RM: The dendritic cell system and
its role in immunogenicity. Ann Rev Immunol. 9:271–296. 1991.
View Article : Google Scholar
|
5
|
Zitvogel L, Mayordomo JI, Tjandrawan T,
DeLeo AB, Clarke MR, Lotze MT and Storkus WJ: Therapy of murine
tumors with tumor peptide-pulsed dendritic cells: dependence on T
cells, B7 costimulation and T helper cell I-associated cytokines. J
Exp Med. 183:183–187. 1996. View Article : Google Scholar
|
6
|
Philip R, Brunette E, Ashton J, et al:
Tansgene expression in dendritic cells to induce antigen-specific
cytotoxic T cells in healthy donors. Cancer Gene Ther. 5:236–246.
1998.PubMed/NCBI
|
7
|
McArthur JG and Mulligan RC: Induction of
protective anti-tumor immunity by gene-modified dendritic cells. J
Immunother. 21:41–47. 1998. View Article : Google Scholar : PubMed/NCBI
|
8
|
Palmer DH, Midgley RS, Mirza N, et al: A
phase II study of adoptive immunotherapy using dendritic cells
pulsed with tumor lysate in patients with hepatocellular carcinoma.
Hepatology. 49:124–132. 2009. View Article : Google Scholar
|
9
|
Romani N, Gruner S, Brang D, et al:
Proliferating dendritic cell progenitors in human blood. J Exp Med.
180:83–93. 1994. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sallusto F and Lanzavecchia A: Efficient
presentation of soluble antigen by cultured human dendritic cells
is maintained by granulocyte/macrophage colony stimulating factor
plus interleukin 4 and down regulated by tumor necrosis factor
alpha. J Exp Med. 179:1109–1118. 1994. View Article : Google Scholar : PubMed/NCBI
|
11
|
Young JW and Inaba K: Dendritic cells as
adjuvants for class I major histocompatibility complex-restricted
antitumor immunity. J Exp Med. 183:7–11. 1996. View Article : Google Scholar : PubMed/NCBI
|
12
|
Paglia P, Chiodoni C, Rodolfo M and
Colombo MP: Murine dendritic cells loaded in vitro with soluable
protein prime cytotoxic T lymphocytes against tumor antigen in
vivo. J Exp Med. 183:317–322. 1996. View Article : Google Scholar : PubMed/NCBI
|
13
|
Alexander M, Salgaller ML, Celis E, Sette
A, Barnes WA, Rosenberg SA and Steller MA: Generation of
tumor-specific cytotoxic T lymphocytes from peripheral blood of
cervical cancer patients by in vitro stimulation with a synthetic
human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol.
175:1586–1593. 1996. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sonderbye L, Feng S, Yacoubian S, Buehler
H, Ahsan N, Mulligan R and Langhoff E: In vivo and in vitro
modulation of immune stimulatory capacity of primary dendritic
cells by adenovirus-mediated gene transduction. Exp Clin
Immunogenet. 15:100–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kim CJ, Prevette T, Cormier J, et al:
Dendritic cells infected with poxviruses encoding MART-1/Melan A
sensitize T lymphocyte in vitro. J Immunother. 20:276–286. 1997.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Liu Y, Butterfield LH, Fu X, et al:
Lentivirally Engineered DC activate AFP-specific T cells which
Inhibit Hepatocellular Carcinoma Growth in vitro and in vivo. Int J
Oncol. 39:245–253. 2011.PubMed/NCBI
|
17
|
Jooss K, Yang Y, Fisher KJ and Wilson JM:
Transduction of dendritic cells by DNA viral vectors directs the
immune response to transgene products in muscle fibers. J Virol.
72:4212–4223. 1998.PubMed/NCBI
|
18
|
Yang Y, Su Q and Wilson JM: Role of viral
antigens in destructive cellular immune responses to adenovirus
vector-transduced cells in mouse lungs. J Virol. 70:7209–7212.
1996.PubMed/NCBI
|
19
|
Veron P, Allo V, Rivière C, Bernard J,
Douar AM and Masurier C: Major subsets of human dendritic cells are
efficiently transduced by self-complementary adeno-associated virus
vectors 1 and 2. J Virol. 81:5385–5394. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dullaers M and Thielemans K: From pathogen
to medicine: HIV-1-derived lentiviral vectors as vehicles for
dendritic cell based cancer immunotherapy. J Gene Med. 8:3–17.
2006. View
Article : Google Scholar
|
21
|
Warrington KH Jr and Herzog RW: Treatment
of human disease by adeno-associated viral gene transfer. Hum
Genet. 119:571–603. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chiriva-Internati M, Liu Y, Salati E, et
al: Efficient generation of cytotoxic T lymphocytes against
cervical cancer cells by adeno-associated virus/human
papillomavirus type 16 E7 antigen gene transduction into dendritic
cells. Eur J Immunol. 32:30–38. 2002. View Article : Google Scholar
|
23
|
Samulski RJ, Berns KI, Tan M and Muzyczka
N: Cloning of adeno-associate d virus into pBR322: rescue of intact
virus from the recombinant plasmid in human cells. Proc Natl Acad
Sci. 79:2077–2081. 1982. View Article : Google Scholar
|
24
|
Morinaga T, Sakai M, Wegmann TG and
Tamaoki T: Primary structures of human alpha-fetoprotein and its
mRNA. Proc Natl Acad Sci. 80:4604–4608. 1983. View Article : Google Scholar : PubMed/NCBI
|
25
|
Collaco RF, Cao X and Trempe JP: A helper
virus-free packaging system for recombinant adeno-associated virus
vectors. Gene. 238:397–405. 1999. View Article : Google Scholar : PubMed/NCBI
|
26
|
Auricchio A, Hildinger M, O’Connor E, Gao
GP and Wilson JM: Isolation of highly infectious and pure
adeno-associated virus type 2 vectors with a single-step
gravity-flow column. Hum Gene Ther. 12:71–76. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Devos R, Cheroutre H, Taya Y, Degrave W,
Van Heuverswyn H and Fiers W: Molecular cloning of human immune
interferon cDNA and its expression in eukaryotic cells. Nucleic
Acids Res. 10:2487–2501. 1982. View Article : Google Scholar : PubMed/NCBI
|
28
|
Steinman RM: Dendritic cells: from the
fabric of immunology. Clin Invest Med. 27:231–236. 2004.PubMed/NCBI
|
29
|
Bender A, Sapp M, Feldman M, et al:
Dendritic cells as immunogens for human CTL responses. Adv Exp Med
Biol. 417:383–387. 1997. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sheng KC, Pietersz GA, Wright MD and
Apostolopoulos V: Dendritic cells: activation and
maturation-applications for cancer immunotherapy. Curr Med Chem.
12:1783–1800. 2005. View Article : Google Scholar
|
31
|
Zou W: Immunosuppressive networks in the
tumor environment and their therapeutic relevance. Nat Rev Cancer.
5:263–274. 2005. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Nonacs R1, Humborg C, Tam JP and Steinman
RM: Mechanisms of mouse spleen dendritic cell function in the
generation of influenza-specific cytolytic T lymphocytes. J Exp
Med. 176:519–529. 1992. View Article : Google Scholar : PubMed/NCBI
|
33
|
Banchereau J, Briere F, Caux C, et al:
Immunobiology of dendritic cells. Annu Rev Immunol. 18:767–811.
2000. View Article : Google Scholar : PubMed/NCBI
|
34
|
Jaraquemada D, Marti M and Long EO: An
endogenous processing pathway in vaccinia virus-infected cells for
presentation of cytoplasmic antigens to class II-restricted T
cells. J Exp Med. 172:947–954. 1990. View Article : Google Scholar : PubMed/NCBI
|
35
|
Schuhbauer DM, Mitchison NA and Mueller B:
Interaction within clusters of dendritic cells and helper T cells
during initial Th1/Th2 commitment. Eur J Immunol. 30:1255–1262.
2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
McClellan AD, Heiser A and Hart DN:
Induction of dendritic cell costimulator molecule expression is
suppressed by T cells in the absence of antigen-specific
signalling: role of cluster formation, CD40 and HLA-class II for
dendritic cell activation. Immunol. 98:171–180. 1999. View Article : Google Scholar
|
37
|
Stuhler G, Zobywalski A, Grünebach F, et
al: Immune regulatory loops determine productive interactions
within human T lymphocyte-dendritic cell clusters. Proc Natl Acad
Sci USA. 96:1532–1535. 1999. View Article : Google Scholar : PubMed/NCBI
|